H.R. 7148 (119th)Bill Overview

Consolidated Appropriations Act, 2026

Economics and Public Finance|Economics and Public Finance
Sponsor
Cosponsors
Support
Republican
Introduced
Jan 20, 2026
Discussions
Bill Text
Current stageFloor

Passed Senate, under the order of 1/30/2026, having achieved 60 votes in the affirmative, with amendments by Yea-Nay Vote. 71 - 29. Record Vote Number: 20.

Introduced
Committee
Floor
President
Law
Congressional Activities
01 · The brief

The Consolidated Appropriations Act, 2026 is a large omnibus spending bill that funds federal agencies for FY2026 and includes multiple appropriations divisions (Defense; Labor/HHS/Education; Transportation/HUD; Financial Services; State/Foreign Operations; and others), policy riders, procurement authorities, domestic sourcing requirements, foreign security assistance authorities and reporting requirements, health care-related reforms (including pharmacy benefit manager rebate remittance and generic drug transparency), and various program-specific directives and restrictions.

Passage80/100

Must‑fund nature, broad inclusion of constituent and programmatic items, and extensive compromise language raise likelihood despite fiscal size and some contested riders.

CredibilityAligned

Relative to its intended legislative type (a consolidated appropriations Act), this bill is well-constructed: it provides detailed appropriations by account and program, integrates with existing statutes, and embeds multiple execution, oversight, and anti-abuse provisions. It also contains substantive statutory amendments and programmatic provisions beyond pure funding.

Contention52/100

Progressive objects to large defense spending while praising PBM and drug transparency

02 · What it does

Who stands to gain, and who may push back.

Who this appears to help vs burden50% / 50%
Targeted stakeholdersFederal agencies
Likely helped
  • Targeted stakeholdersLarge defense procurement and RDT&E funding supports the defense industrial base and defense jobs.
  • Targeted stakeholdersShipbuilding and weapons procurement awards sustain shipyards and suppliers through 2030.
  • Targeted stakeholdersBuy American and domestic sourcing provisions likely boost U.S. manufacturing contracts and supplier demand.
Likely burdened
  • Federal agenciesLarge appropriations increase federal outlays, potentially widening deficits absent offsets.
  • Targeted stakeholdersDomestic sourcing and Buy American rules may increase procurement costs and reduce supplier competition.
  • Targeted stakeholdersBroad transfer and waiver authorities concentrate discretionary spending power with Defense leadership.
03 · Why people split

Why the argument around this bill splits.

Progressive objects to large defense spending while praising PBM and drug transparency
Progressive55%

This persona sees the bill as a mixed outcome.

They welcome health-care provisions that increase drug-market transparency and curb PBM rebate retention, but criticize very large defense and procurement appropriations and limited climate or social investment priorities in the text provided.

Split reaction
Centrist75%

A pragmatic centrists view the bill as necessary annual governance: it funds core national defense and domestic programs while adding operational oversight and targeted reforms.

They weigh structural improvements and transparency against the bill’s size and the political tradeoffs required to pass an omnibus.

Leans supportive
Conservative85%

This persona generally approves: the bill funds robust defense capabilities, supports domestic industry via Buy American and steel/ball-bearing rules, preserves procurement and shipbuilding in U.S. yards, and contains authorities needed for security assistance.

They view some healthcare market rules as regulatory overreach but not deal-breaking.

Leans supportive
04 · Can it pass?

The path through Congress.

Introduced

Reached or meaningfully advanced

Committee

Reached or meaningfully advanced

Floor

Reached or meaningfully advanced

President

Still ahead

Law

Still ahead

Passage likelihood80/100

Must‑fund nature, broad inclusion of constituent and programmatic items, and extensive compromise language raise likelihood despite fiscal size and some contested riders.

Scope and complexity
86%
Scopesweeping
86%
Complexityhigh
Why this could stall
  • Presence and impact of any highly controversial hidden riders
  • CBO/score fiscal offsets and long‑term budget effects
05 · Recent votes

Recent votes on the bill.

SENATE · Jan 30, 2026

Bill Passed (71-29, 3/5 majority required)

71 yes · 29 no

On Passage of the Bill H.R. 7148

Yes 71% No 29%
Showing a quick cross-section of legislators, with followed members first when available.
06 · Go deeper

Go deeper than the headline read.

Included on this page

Progressive objects to large defense spending while praising PBM and drug transparency

Must‑fund nature, broad inclusion of constituent and programmatic items, and extensive compromise language raise likelihood despite fiscal…

Unlocked analysis

Relative to its intended legislative type (a consolidated appropriations Act), this bill is well-constructed: it provides detailed appropriations by account and program, integrates with existing statutes, and embeds mul…

Go beyond the headline summary with full stakeholder mapping, legislative design analysis, passage barriers, and lens-by-lens tradeoff breakdowns.

Perspective breakdownsPassage barriersLegislative design reviewStakeholder impact map
Open full analysis